Penn animal study identifies new DNA weapon against avian flu

July 02, 2008

Broad application of DNA vaccine could allow for quick mobilization during an epidemic

PHILADELPHIA - Researchers at the University of Pennsylvania School of Medicine have identified a potential new way to vaccinate against avian flu. By delivering vaccine via DNA constructed to build antigens against flu, along with a minute electric pulse, researchers have immunized experimental animals against various strains of the virus. This approach could allow for the build up of vaccine reserves that could be easily and effectively dispensed in case of an epidemic. This study was published last week in PLoS ONE.

"This is the first study to show that a single DNA vaccine can induce protection against strains of pandemic flu in many animal models, including primates," says David B. Weiner, Ph.D., Professor of Pathology and Laboratory Medicine. "With this type of vaccine, we can generate a single construct of a pandemic flu vaccine that will give much broader protection."

Traditional vaccines expose a formulation of a specific strain of flu to the body so it can create immune responses against that specific strain. Conversely, a DNA vaccine becomes part of the cell, giving it the blueprint it needs to build antigens that can induce responses that target diverse strains of pandemic flu.

Avian flu is tricky. Not only is it deadly, but it mutates quickly, generating different strains that escape an immune response targeted against one single strain. Preparing effective vaccines for pandemic flu in advance with either live or killed viruses, which protect against only one or few cross-strains, is therefore very difficult. How to predict which strain of avian flu may appear at any time is difficult. "We are always behind in creating a vaccine that can effectively protect against that specific strain," notes Weiner.

Instead of injecting a live or killed virus, Penn researchers injected three different species of animal models with synthetic DNA vaccines that are not taken from the flu microbe, but trick the immune system into mounting a broad response against pandemic flu, including strains to which the immune system was never exposed. Antibodies induced by the vaccine rapidly reached protective levels in all three animal species.

"The synthetic DNA vaccines designed in this study customize the antigen to induce more broad immune responses against the pathogen," says Weiner.

Researchers found evidence of two types of immune responses - T lymphocytes and antibodies -- in all three types of animal models. Two types of animal models (mice and ferrets) were protected from both disease and mortality when exposed to avian flu.

To ensure increased DNA delivery, the researchers administered the vaccine in combination with electroporation, a small, harmless electric charge that opens up cell pores facilitating increased entry of the DNA vaccine into cells.

If proven in humans, this research could lead the way to preparing against an outbreak of avian flu. Because these synthetic DNA vaccines are effective against multiple cross strains, vaccines could be created, stockpiled, prior to a pandemic, and thus be delivered quickly in the event of an outbreak, surmise the researchers.

This study has shown other advantages of DNA vaccines. On one hand, killed vaccines, which involve the injection of a dead portion of a virus, are relatively safe but usually effective at producing only a strong cellular immunity. Live vaccines, which involve the injection of a form of a live virus, can have increased manufacturing and some safety issues. Both of these vaccine strategies may have concerns in persons with certain allergies (egg for example) as current manufacturing methods rely on egg based production technologies. On the other hand, DNA vaccines preclude the need to create live tissue samples, which presents risk to those working with the virus.

"DNA vaccines have the benefits and avoid many conceptual negatives of other types of traditional vaccines," says Weiner.

This research also has implications for non-avian types of flu. Every year, scientists try to guess what strain of the year will be that creates the common flu. Sometimes their educated guess is wrong, which is why last year's influenza vaccine worked only 30 percent of the time. Designing traditional vaccines in combination with the DNA platform may be a partial solution to this dilemma, predicts Weiner.

University of Pennsylvania School of Medicine

---

---

	The Fatal Strain: On the Trail of Avian Flu and the Coming Pandemic by Alan Sipress (Author) A riveting account of why science alone can't stop the next pandemic. In 2009, Swine Flu reminded us that pandemics still happen, and award- winning journalist Alan Sipress reminds us that far worse could be brewing. When a highly lethal strain of avian flu broke out in Asia in 2003 and raced westward, Sipress, as a reporter for The Washington Post, tracked the virus across nine countries, watching its secrets elude the world's brightest scientists and most intrepid disease hunters. A vivid portrayal of the struggle between man and microbe, The Fatal Strain is a fast-moving account that weaves cultural, political, and scientific strands into a tale of inevitable pandemic.
	Dread: How Fear and Fantasy Have Fueled Epidemics from the Black Death to Avian Flu by Philip Alcabes (Author) Deaths from epidemic disease are rare in the developed world, yet in our technically and medically advanced society, an ever-present risk of disease has created an industry out of fear.As Philip Alcabes persuasively argues in Dread, our anxieties about epidemics often stray from the facts on the ground. In a fascinating exploration of the social and cultural history of epidemics, Alcabes delivers a different narrative of disease—one that requires that we reexamine our choice of enemies, and carefully consider the potential motivation of epidemic alarm-bells to further medical, moral, or political campaigns.
	HHS orders 2 million avian flu vaccine doses.(News): An article from: Skin & Allergy News by Michele G. Sullivan (Author) This digital document is an article from Skin & Allergy News, published by International Medical News Group on December 1, 2004. The length of the article is 607 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: HHS orders 2 million avian flu vaccine doses.(News) Author: Michele G. Sullivan Publication: Skin & Allergy News (Magazine/Journal) Date: December 1, 2004 Publisher: International Medical News Group Volume: 35 Issue: 12 Page: 4(1) Distributed by Thomson...
	Biosecurity tight with Avian Flu looming.: An article from: Arkansas Business by Bill Bowden (Author) This digital document is an article from Arkansas Business, published by Thomson Gale on October 24, 2005. The length of the article is 733 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Biosecurity tight with Avian Flu looming. Author: Bill Bowden Publication: Arkansas Business (Magazine/Journal) Date: October 24, 2005 Publisher: Thomson Gale Volume: 22 Issue: 42 Page: 14(1) Distributed by Thomson...
	A rapid analysis of Avian Influenza patents in the Esp@cenet^(R) database - R&D strategies and country comparisons [An article from: World Patent Information] by H. Dou (Author), Y. Bai (Author) This digital document is a journal article from World Patent Information, published by Elsevier in 2007. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser. Description: Avian Influenza is a very hot field. In this rapid analysis we show how patents can be used to rapidly determine the trends of R&D in this field as well as some differences between different groups of countries, academic institutions and companies.
	The Monster at Our Door: The Global Threat of Avian Flu by Mike Davis (Author) From the acclaimed writer The Nation calls the "master of disaster prose," a terrifying forecast of a new global threat. "We are talking at least seven million deaths, but maybe more—10 million, 20 million, and the worst case, 100 million."—Shigeru Omi, Regional Director, western pacific office of the World Health Organization, November 2004 Avian influenza is a viral asteroid on a collision course with humanity. In 1918, a pandemic strain of influenza killed at least 40 million people in three months. Now, leading researchers believe, another world catastrophe is imminent. A virus of astonishing lethality, known as H5N1, has become entrenched in the poultry and wild bird populations of East Asia. It kills two out of every three people it infects. The World Health...
	Avian Flu (Deadly Diseases and Epidemics) by Jeffrey N. Sfakianos (Author)
	New York Times Deadly Invaders: Virus Outbreaks Around the World, from Marburn Fever to Avian Flu by Denise Grady (Author) An epidemic strikes the United States, plunging the country into chaos. New York Times medical reporter Denise Grady uses this terrifying scenario, taken from the pages of a U.S. government report on the potential outcome of a pandemic, as the starting point for a journey into the gripping world of emerging diseases. In search of a better understanding of these often deadly diseases, Grady heads to Angola, the site of the 2005 Marburg virus epidemic, a disease closely related to Ebola. On the ground, and sometimes frighteningly close to victims of the disease, Denise explores the realities of health care in the developing world, and its potential effects on our own welfare. With supplemental sidebars that explain key scientific and social issues and in-depth chapters on the...
	Keeping the flu bug out of the office.(EMERGENCY preparedness guide)(Avian influenza): An article from: New Hampshire Business Review by Sue Masaracchia-Roberts (Author) This digital document is an article from New Hampshire Business Review, published by Thomson Gale on November 24, 2006. The length of the article is 626 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Keeping the flu bug out of the office.(EMERGENCY preparedness guide)(Avian influenza) Author: Sue Masaracchia-Roberts Publication: New Hampshire Business Review (Magazine/Journal) Date: November 24, 2006 Publisher: Thomson Gale Volume: 28 Issue: 25 Page: 34(1) Distributed by Thomson...
	The Thin White Line: A History of the 2012 Avian Flu Pandemic in Canada by Craig DiLouie (Author) On September 15, 2012, a restaurant worker enters a hospital in China's Guangdong province complaining of flu symptoms. This single event ignites a conflagration of disease that burns its way around the world, leaving death, recession, revolution and war in its wake. In THE THIN WHITE LINE: A History of the 2012 Avian Flu Pandemic in Canada, Craig DiLouie presents a terrifying vision about how a pandemic might unfold, focusing on the Canadian experience but relevant to any country. Reading as if it were a non-fiction book describing a pandemic that has already happened, THE THIN WHITE combines a realistic, meticulously researched scenario with dramatic firsthand accounts of people who survived these tragic times. Global health officials have warned the world that a flu pandemic is an...